kabutan

TRANSGENIC GROUP INC.(2342) Summary

2342
TSE Standard
TRANSGENIC GROUP INC.
281
JPY
-4
(-1.40%)
Mar 13, 3:30 pm JST
1.76
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
117.0
PBR
0.95
Yield
ー%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
280 JPY 1.75 USD
Previous Close Mar 12
285 JPY 1.79 USD
High Mar 13, 9:00 am
282 JPY 1.77 USD
Low Mar 13, 9:25 am
274 JPY 1.72 USD
Volume
104,000
Trading Value
0.03B JPY 0.18M USD
VWAP
278.62 JPY 1.75 USD
Minimum Trading Value
28,100 JPY 176 USD
Market Cap
4.78B JPY 0.03B USD
Number of Trades
148
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Slightly High
1-Year Average
674
1-Year High Dec 4, 2025
20,104
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 0 1,407,800
Feb 27, 2026 0 1,515,900
Feb 20, 2026 0 1,650,800
Feb 13, 2026 0 1,533,500
Feb 6, 2026 0 1,463,300
Company Profile
TRANSGENIC GROUP INC. is a biotech venture supporting drug discovery research. The company specializes in genetic analysis using mice and is expanding through succession-based M&A.
Sector
Services
TRANSGENIC GROUP INC. operates two main business segments: drug discovery support and investment/consulting. In the drug discovery support segment, the company offers services such as genetically modified mouse production, antibody production, glycan analysis and synthesis, preclinical trials, and clinical trial outsourcing. The investment and consulting segment focuses on promoting new businesses through M&A and supporting business succession and revitalization. This segment includes various activities such as the sale of electrical products, import and sale of Western tableware, development and sale of information and communication equipment, import and sale of auxiliary materials for multi-layered glass and glass processing equipment, and import and sale of printer toners.